Bullfrog AI identifies 3 novel colorectal cancer targets via bfLEAP platform; validation with JCVI planned

BullFrog AI Holdings, Inc.

14 candidates over-expressed in colon tumors identified using TCGA data; 3 are novel, 6 near-novel.
bfLEAP platform reduced candidate list from >3,000 traditional analysis to 14 actionable targets.
Target validation to be conducted with J. Craig Venter Institute under existing collaboration.
Colorectal cancer market valued at $11.5B in 2022, projected CAGR 4.7% through 2030.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.